Top Pharmaceutical Companies in Europe List by Market Cap as on July-30-2023

For year ending December-2022, Novo Nordisk Annual Revenue was 176,954 Million DKK and Net Income was 55,525 Million DKK.

For year ending December-2021, Novo Nordisk Annual Revenue was 140,800 Million DKK and Net Income was 47,757 Million DKK.

Roche Holding annual revenues for year ending December 2022 was 63.28 billion CHF. (Previous year : 62.8 billion CHF)

Roche Holding annual operating profit for year ending December 2022 is 17.47 billion CHF. (Previous year : 18.15 billion CHF)

As on December 2022, Roche Holding has 103,613 employees, 29 research and development sites in Pharmaceuticals and Diagnostics worldwide, 23 manufacturing sites in Pharmaceuticals and Diagnostics worldwide.

63 million patients treated with medicines of Roche Holding.

AstraZeneca annual revenue was 44,351 million USD for year ending Dec-2022 and annual operating profit was 3,757 million USD and annual net income was 3,288 million USD for year ending Dec-2022.

AstraZeneca has 83,500 employees as on 2022 when compared to with 76,100 employees as on 2020 and 70,600 employees as on 2019.

AstraZeneca has total assets of 96,483 million USD as on Dec-2022 when compared to 66,729 million USD as on Dec-2020.

AstraZeneca Product Sales split of 44,351 Million USD by Disease Area for year ending Dec-2022

• 11,745 Million USD from Emerging Markets (Previous year  12,281  million USD)
• 17,920 Million USD from USA.  (Previous year 2021 : 12,228 million USD)
• 8,738 Million USD from Europe. (Previous year 2021 : 8,050 million USD)
• From the rest of the World, it is 5,948 Million USD (Previous year 2021 : 4,858 million USD)

As on December-2022, Astrazeneca has 83,500 employees and out of that

• 16,500 employees are from USA.
• 10,700 employees are from UK
• 16,500 employees are from China
• 7,100 employees are from Sweden
• 11,400 employees are from Other Europe has 
• 7,200 employees are from Other Asia Pacific
• 1,200 employees are from Canada and 2,400 employees are from Middle East and Africa and 2,000 employees are from Russia and 3,500 employees are from Japan and 1,000 employees are from Australia and New Zealand.

Astrazeneca company acquired Alexion Pharmaceuticals for 39 Billion USD in 2020.

Novartis annual revenue was 51.83 billion USD for year ending Dec-2022 and annual operating profit was 9.19 billion USD and annual net income was 6.95 billion USD for the same period.

Novartis had over 101,703 employees worldwide as on 2022.

Split of Novartis annual revenue 50,545 billion USD for year ending Dec-2022, Innovative Medicines business segment earned 41,296 million USD revenue and Sandoz business segment earned 9,249 million USD revenue.

Within the Innovative Medicines business segment:
Cardiovascular division earned 4,756 million USD revenue.
Immunology division earned 7,287 million USD revenue.
Neuroscience division earned 5,051 million USD revenue.
Solid Tumors division earned 4,723 million USD revenue.
Hematology division earned 6,452 million USD revenue.
Other Promoted Brands division earned 3,127 million USD revenue.
Established Brands division earned 9,900 million USD revenue.

As on 2022, Sanofi had 91,573 employees across 100 countries.

For year ending Dec-2022, Sanofi  annual revenue was 45,389 million EUR and annual net income was 8,371 million EUR during the same period.

As on 2022, Sanofi had 59 manufacturing sites and 20 R&D sites.

Sanofi annual revenue for year ending Dec-2022 by Geographical Regions:

• USA annual revenue was 18.3 billion EUR.
• Europe annual revenue was 10 billion EUR.
• Rest of World revenue was 14.7 billion EUR.

Sanofi annual revenues for year ending Dec-2022 by business segments:

• Specialty Care business segment revenue was 16.5 billion EUR.
• General Medicines business segment revenue was 14.2 billion EUR.
• Vaccines business segment was 7.2 billion EUR.
• Consumer Healthcare business segment revenue was 5.1 billion EUR.

As on 2021, Sanofi has annual revenues of 39.1 Billion EUR and annual net income of 6.2 Billion USD

Merck annual revenue was 22,232 Million EUR and annual net income was 3,326 Million EUR for year ending Dec-2022.

Merck annual revenue was 19,687 Million EUR and annual net income was 3,055 Million EUR for year ending Dec-2021.

Merck had 64,232 employees as on 2022.

GSK annual revenue was 29,324 Million GBP and annual net income was 14,956 Million GBP for year ending Dec-2022.

GSK annual revenues for year ending Dec-2021 was 34,144 million GBP and annual operating income was 6,165 million GBP and annual net income of 4,385 million GBP.

GSK had 70,000 employees as on 2022.

As on 2021, GSK has over 90,000 employees across 92 countries and work directly with 37,500 suppliers.

Bayer annual revenue was 50,739 Million EUR and annual net income was 4,150 Million EUR for year ending Dec-2022.

Bayer annual revenue was 44,081 Million EUR and annual net income was 1,000 Million EUR for year ending Dec-2021.

Bayer had 101,369 employees as on 2022.

Bayer Company has 99,538 Employees as on May-2021.